Rosalyn (aged 62) has had a long and distinguished career during which she has held a number of high profile executive and non-executive positions.
She is currently a non-executive director of Axa UK Ltd, a role she has held since 2012, and since 2007 has also been a non-executive director for Optos plc, a main market listed medical technology company.
Between 1999 and 2006, she was chief executive of Hemscott Group Ltd, the UK data company which merged with US based i-Deal LLC in 2006 to form Ipreo Holding LLC, where Rosalyn held the role of Chairman until 2009. Prior to this, she worked for Reuters Group plc, where she held a number of senior roles, leaving the company as Managing Director, Reuters Information in 1999
Patrick Vaughan, Executive Chairman of LondonMetric, commented: “Ros brings extensive experience to LondonMetric, having been responsible for running a number of companies and business units over the years which will complement the existing expertise of the Board.”
About LondonMetric Property Plc
LondonMetric (ticker: LMP), a UK REIT, aims to deliver attractive returns for shareholders through a strategy of increasing income and improving capital values. It invests across the UK in Retail and Distribution properties as well as Greater London real estate opportunities. It employs an occupier-led approach to property investments through opportunistic acquisitions, joint ventures, active asset management and short cycle developments. The asset focus is on properties with enduring occupier appeal providing opportunities to improve both rental values and the security and longevity of income; and limited risk redevelopments with the aim of enhancing shareholder returns.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.